Hyperthermia based individual in situ recombinant vaccine enhances lymph nodes drainage for de novo antitumor immunity
Open Access
- 26 February 2022
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (8) , 3398-3409
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81874304, 81901878, U1804183)
- China Postdoctoral Science Foundation (2019M662553)
- Education Department of Henan Province (20HASTIT049)
This publication has 51 references indexed in Scilit:
- Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and ImmunotherapyVaccines, 2015
- Partial Mitigation of Gold Nanoparticle Interactions with Human Lymphocytes by Surface Functionalization with A ‘Mixed Matrix‘Nanomedicine, 2014
- Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune responseBiomaterials, 2014
- Quasi-spherical silver nanoparticles: Aqueous synthesis and size control by the seed-mediated Lee–Meisel methodJournal of Colloid and Interface Science, 2013
- Cross-presentation by dendritic cellsNature Reviews Immunology, 2012
- Gold Nanocages: From Synthesis to Theranostic ApplicationsAccounts of Chemical Research, 2011
- Gold Nanocages as Photothermal Transducers for Cancer TreatmentSmall, 2010
- Exceptionally High Payload of Doxorubicin in Hollow Gold Nanospheres for Near-Infrared Light-Triggered Drug ReleaseACS Nano, 2010
- A Quantitative Study on the Photothermal Effect of Immuno Gold Nanocages Targeted to Breast Cancer CellsACS Nano, 2008
- Facile synthesis of Ag nanocubes and Au nanocagesNature Protocols, 2007